NCI Drug Dictionary
The NCI Drug Dictionary contains technical definitions and synonyms for drugs/agents used to treat patients with cancer or conditions related to cancer. Each drug entry includes links to check for clinical trials listed in NCI's List of Cancer Clinical Trials.
- fluorine F 18 L-glutamate derivative BAY94-9392
A radioconjugate composed of the radionuclide fluorine F 18 conjugated to the L-glutamate derivative, (S)-4-(3-fluoropropyl)-L-glutamic acid (FSPG), targeting the cystine/glutamate transporter protein (xCT or SLC7A11), which is a subunit of the transport system xc(-), with potential imaging activity upon positron emission tomography (PET). Upon intravenous administration, the FSPG moiety of BAY94-9392 specifically binds to xCT and BAY94-9392 is subsequently taken up by the cell via xc(-). Upon uptake, xc(-) activity can be assessed and tumor cells can be detected and imaged by PET. System xc(-), a sodium-independent, heterodimeric transporter, mediates the cellular uptake of cystine in exchange for intracellular glutamate at the plasma membrane; although, it will take up glutamate as well. Xc(-) shows increased activity in certain tumor cells compared to normal, healthy cells due to increased metabolic activity in tumor cells; it plays a key role in tumor cell proliferation, progression and chemoresistance as well as in the management of oxidative stress. Check for active clinical trials using this agent. (NCI Thesaurus)
Synonym: (4S)-(3-[F-18]fluoropropyl)-L-glutamic acid
Code name: BAY94-9392
- (S)-4-(3-18F-fluoropropyl)-L-glutamic acid